Levoxyl recall (Pfizer)
DrugClass IIOngoing
Summary: Pfizer is recalling Levoxyl (levothyroxine sodium tablets, USP), tablets, 175 mcg, 1000-count bottle, Rx only, Distributed by Pfizer Inc., New York, NY 10017, Made in Austria. NDC 60793-859-10. Reason: Subpotent Drug: confirmed out-of-specification (OOS) assay during stability testing.
What is being recalled
Levoxyl (levothyroxine sodium tablets, USP), tablets, 175 mcg, 1000-count bottle, Rx only, Distributed by Pfizer Inc., New York, NY 10017, Made in Austria. NDC 60793-859-10
Why
Subpotent Drug: confirmed out-of-specification (OOS) assay during stability testing.
How serious is it
Class II is the middle level: using or being exposed to this product may cause temporary or medically reversible health problems, and the chance of serious harm is remote.
Where it was sold
US Nationwide and Puerto Rico (states named: Puerto Rico)
How to tell if yours is affected
Lot # 24W07, Exp: 11/30/2026
What to do
Check the product name, lot number and expiration date on your package against the codes above. If they match, do not stop taking a prescription medicine without talking to your doctor or pharmacist first; ask them about a replacement. Return or dispose of the product as your pharmacy advises.
Recall facts
| Recall number | D-0051-2027 |
| Category | Drug |
| Agency | U.S. Food and Drug Administration (FDA) |
| Severity | Class II |
| Status | Ongoing |
| Recall started | September 29, 2026 |
| Reported | October 28, 2026 |
| Company | Pfizer |
| Company location | Manhattan, NY, United States |
| Initiated by | Voluntary: Firm initiated |
| Quantity | 134 1000-count bottles |
More recalls from Pfizer · all drug recalls · recalls from September 2026